Category Archives: Uncategorized

Clinical evidence under the EU Medical Device Regulation: More firework on the way.

Posted on January 1, 2018 by

The EU Medical Device Regulation (MDR) and the In Vitro Diagnostic device Regulation (IVDR) entered into force, local governments published guidance how to deal with the new medical device regulations, there is debate on the implementation of the MEDDEV 2.7/1 … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

DUTCH HEALTH INSPECTION – THE 4 KNOWS OF THE CONFERENCE ON CLINICAL TRIALS WITH MEDICAL DEVICES

Posted on February 25, 2017 by

The Dutch Health Inspection (IGZ) organized an invitational conference on clinical research with medical devices end of last year. Representatives of the different stakeholders, such as manufacturers, competent authorities, Ethics Committee’s, and health care providers were present during this conference … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , | Leave a comment

INFORMED CONSENT – 5 CRITICAL ELEMENTS TO MONITOR

Posted on February 5, 2017 by

Ensuring proper informed consent in clinical studies is a critical process, that protects the rights, safety, and welfare of human subjects involved. It will require even more attention under the new GDPR and with the globalization of clinical trials. Although … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , | 1 Comment

EU MEDICAL DEVICE CLINICAL EVIDENCE 2016/2017

Posted on December 27, 2016 by

The year 2016 has been a very interesting one from clinical perspective with many developments in the EU medical device regulatory environment, and I am sure we are facing an even more interesting one coming up: The latest draft of … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

MUTUAL ACCEPTANCE OF CLINICAL STUDY DATA IN DAILY PRACTICE

Posted on December 11, 2016 by

During the congress on clinical trials for medical devices in Berlin, I spoke on the mutual acceptance of clinical trial data. A short version of my presentation you can find on SlideShare: Globalization of Clinical Trials: Mutual acceptance of Medical … Continue reading →

Posted in Uncategorized | Tagged , , , , | Leave a comment

GENERAL DATA PROTECTION REGULATION – 5 CLINICAL ASPECTS

Posted on October 30, 2016 by

As mentioned in my previous post on the MEDDEV 2.7/1 revision 4, the second quarter of 2016 is characterized by several big steps from clinical evidence perspective: Besides the publication of the new version of the MEDDEV 2.7/1, consensus was … Continue reading →

Posted in Uncategorized | Tagged , , , , , | 2 Comments